Trials / Completed
CompletedNCT05125796
Analgesic Use for Pain Relief in Scorpion Sting
Comparison of iv Paracetamol, iv Dexketoprofen and Topical Lidocaine in Scorpion Sting: a Placebo Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 106 (actual)
- Sponsor
- Adiyaman University Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
In scorpion stings, patients mostly apply with the complaint of pain. Emergency physicians need to relieve this pain quickly.
Detailed description
Aim: In this study, the analgesic efficacy of intravenous (IV) paracetamol, IV dexketoprofen trometamol and topical lidocaine will be compared in patients presenting with pain after scorpion sting. Methods: This study is a double-blind, randomized, placebo-controlled study conducted in a tertiary emergency department. Adult patients who applied to the study with no systemic findings after scorpion sting and especially with pain will be randomly assigned to one of 4 groups: IV paracetamol, IV dexketoprofen trometamol, topical lidocaine or placebo. In order to determine the intensity of pain, Visual Analog Pain Score (VAS) will be measured at the time of admission to the emergency department, at the 30th minute and at the 60th minute. Afterwards, the VAS score changes between the groups will be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | paracetamol | 1000 mg intravenous paracetamol in 100 mL normal saline |
| DRUG | Dexketoprofen Trometamol | 50 mg intravenous dexketoprofen Trometamol in 100 mL normal saline |
| DRUG | Lidocaine topical | Application of 5 gr of 5% topical lidocaine |
| DRUG | Placebo | 100 mL intravenous normal saline infusion+ placebo topical pomade application |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2021-10-01
- Completion
- 2021-10-01
- First posted
- 2021-11-18
- Last updated
- 2024-02-08
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05125796. Inclusion in this directory is not an endorsement.